NorthWest Healthcare Properties Real Estate Investment Trust

NWHUF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$462,403$522,678$448,829$374,613
% Growth-11.5%16.5%19.8%
Cost of Goods Sold$112,995$121,374$100,477$68,548
Gross Profit$349,408$401,304$348,352$306,065
% Margin75.6%76.8%77.6%81.7%
R&D Expenses$0$0$3,430$9,441
G&A Expenses$58,174$57,567$47,870$40,203
SG&A Expenses$58,174$57,567$47,870$40,203
Sales & Mktg Exp.$0$0$0$0
Other Operating Expenses-$15,150$0-$15,223-$10,350
Operating Expenses$43,024$46,753$36,077$39,294
Operating Income$306,384$354,551$358,423$357,014
% Margin66.3%67.8%79.9%95.3%
Other Income/Exp. Net-$676,097-$853,576-$153,023$364,201
Pre-Tax Income-$369,713-$499,025$204,924$736,068
Tax Expense-$49,509-$18,289$79,297$124,229
Net Income-$299,757-$347,690$125,627$611,839
% Margin-64.8%-66.5%28%163.3%
EPS-1.21-1.460.532.73
% Growth17.1%-375.5%-80.6%
EPS Diluted-1.21-1.460.522.73
Weighted Avg Shares Out247,784243,292237,322224,127
Weighted Avg Shares Out Dil247,784243,292240,648224,127
Supplemental Information
Interest Income$18,840$46,499$9,180$4,597
Interest Expense$197,702$233,850$163,883$102,168
Depreciation & Amortization$3,671$1,266$1,396$1,382
EBITDA-$168,340-$263,909$353,691$377,561
% Margin-36.4%-50.5%78.8%100.8%